Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Hallmarks of aging
Research brief

Vocal fold bowing and thyroarytenoid myocyte size in aging rats

In this rat study, 18- and 24-month-old animals showed more vocal fold bowing than 4-month-olds, and their thyroarytenoid myofibers were larger, not smaller. [1]

Automatic summary · not editorially reviewed

The key findings

  1. Bowing Index was higher in 18- and 24-month rats than in 4-month rats. [1]

  2. Mean myofiber minimum Feret diameter and cross-sectional area were larger at 18 and 24 months than at 4 months, with no difference between 18 and 24 months. [1]

  3. The authors say aged rats' increased bowing parallels clinical findings in age-related vocal atrophy and propose future mechanism studies. [1]

The source at a glance

Study type / format
Preclinical animal study (abstract).
Population / context
Sprague-Dawley rats aged 4, 18 and 24 months (n = 24).
Summary based on
Study abstract
Original publication
September 25, 2026

Rat ages and vocal fold bowing measured

The study compared Sprague-Dawley rats aged 4, 18 and 24 months (n = 24). Endoscopic video of the vocal folds was scored with a Bowing Index by two independent reviewers. The Bowing Index was higher in 18-month rats than in 4-month rats (mean difference 7.15, 95% confidence interval 4.39–9.90) and also higher in 24-month rats than in 4-month rats (mean difference 4.26, 95% confidence interval 1.50–7.01). The abstract does not report a direct 18- versus 24-month comparison for bowing.

Supporting source [1]

Larger thyroarytenoid myofibers in older rats

The thyroarytenoid muscles were analyzed for myofiber number, minimum Feret diameter and cross-sectional area. Mean minimum Feret diameter was 19.8 ± 1.3 μm at 4 months, 22.1 ± 1.7 μm at 18 months and 22.5 ± 1.5 μm at 24 months. Mean cross-sectional area was 435.8 ± 49.4 μm, 535.2 ± 81.3 μm and 556.6 ± 54.3 μm at 4, 18 and 24 months. Both measures differed between 4 and 18 months and between 4 and 24 months, but not between 18 and 24 months. So the older rats had larger myofibers, which the authors note rather than atrophy.

Supporting source [1]

Rat model parallels clinical findings, mechanisms open

The authors conclude that aged rats showed increased vocal fold bowing, which they describe as paralleling findings in age-related vocal atrophy in people. They also report increased myofiber size in aged rats. The abstract states that future studies will examine mechanisms behind increased myofiber size together with bowing, including shifts in muscle fiber type, compensatory hypertrophy and altered mitochondrial function. These are proposed future directions, not established causes.

Supporting source [1]

How to interpret this

This is an abstract only; the full text was not reviewed. It reports a rat model with 24 animals across three age groups, so it cannot establish causes of human age-related vocal atrophy or confirm that rats mirror human laryngeal aging. The abstract gives no direct 18- versus 24-month bowing comparison and no myofiber number results.

Based on the study abstract; the full paper, tables and supplementary data were not reviewed.

Source & supporting passages

[1]
Correlating Vocal Fold Bowing and Thyroarytenoid Myocyte Dimensions in an Aging Rat Model.

Miller CS, Jaleel Z, Kim BS, Al-Ghezi M, Leong S, Bhatt NK. · europepmc.org · September 25, 2026

Read the quoted passagesIn the language of the original source
  1. Finding 1 ↑

    BI was greater in 18- and 24-month
  2. Finding 2 ↑

    increase in myofiber size
  3. Finding 3 ↑

    paralleling ARVA clinical findings

AI-assisted summary with linked source passages. No independent editorial or clinical review.

Our editorial method

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…